Clinical trial · Observational
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway
"Pilot Study: Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway in the Management of a Patient Treated for Hepatocellular Carcinoma (HCC)"
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project is based on the assumption that the nurse coordinators of the centres have common missions at each of the key stages of patient care. These missions make the care plan more fluid and improve the quality and safety of care as well as the patient's prognosis. The Hypothesis is that co-follow-up by a doctor and a nurse coordinator reduces time between referral to treatment, average lengths of stay, unscheduled readmissions or early emergency visits, compared to follow-up that does not involve a nurse coordinator.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Proportion of the following missions of the coordinator Nurse
- timeFrame
- 12 months
- description
- missions: o Initial contact of the patient with the expert centre * Organisation of the MDT meeting * Organisation of treatment and investigations * Coordination between hospital professionals * Link with community health professionals * Follow-up (post-hospitalization, treatment side effects, etc.) * Information, advice to patients * Psychological support * Implementation of care pathways * Nursing research
Secondary outcomes (8)
- measure
- Timeframe in days between The first contact with the centre and the first interventional radiology treatment.
- timeFrame
- 12 months
- description
- Timeframe in days between The first contact with the centre and the first interventional radiology treatment.
- measure
- Timeframe in days between : The first contact with the centre and the first presentation at a MDT meeting
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * Centre with interventional radiology treatment * Active list of patients followed for a HCC of at least 70 / year * Reply to the feasibility questionnaire within 60 days from receipt of the email Exclusion Criteria: * Patient with a localized HCC diagnosis (BCLC A or B) * Hospitalised for a first interventional radiology treatment (radioembolisation, transarterial chemoembolization or percutaneous ablation) in one of the centres included in the study between July 1, 2017 and December 31, 2017
References
Publications (0)
Data not yet available